PDL BioPharma, Inc. Investing cash flow

Investing cash flow of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending June 29, 2020 was $24.8 Million (a -26792.47% decrease compared to previous quarter)
  • Year-over-year quarterly Investing cash flow decreased by -17.86%
  • Annual Investing cash flow for 2019 was $21.8 Million (a -61.54% decrease from previous year)
  • Annual Investing cash flow for 2018 was $56.7 Million (a -87.64% decrease from previous year)
  • Annual Investing cash flow for 2017 was $459 Million (a -417.55% decrease from previous year)
  • Twelve month Investing cash flow ending June 29, 2020 was $75.7 Million (a 247.81% increase compared to previous quarter)
  • Twelve month trailing Investing cash flow increased by 255.86% year-over-year
Trailing Investing cash flow for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$75.7 Million $21.8 Million $21.8 Million $21.3 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of PDL BioPharma, Inc.

Most recent Investing cash flowof PDLI including historical data for past 10 years.

Interactive Chart of Investing cash flow of PDL BioPharma, Inc.

PDL BioPharma, Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $24.82 $-0.09
2019 $20.72 $30.22 $-29.1 $-0.04 $21.81
2018 $20.18 $-1.67 $16.85 $21.34 $56.7
2017 $34.82 $251.21 $43.79 $129.06 $458.89
2016 $12.34 $-0.5 $-168.84 $12.49 $-144.51
2015 $13.64 $-90.16 $-4.07 $0.94 $-79.65
2014 $10.72 $32.26 $-154.73 $-26.36 $-138.11
2013 $-339.63 $43.29 $-19.6 $19.11 $-296.84
2012 $-34.23 $-44.04 $5.99 $0.57 $-71.71
2011 $8.5 $-0.29 $-1.83 $-30.43 $-24.05
2010 $-10.09 $-14.41 $-12.4 $-36.9

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.